New Zealand markets open in 5 hours 46 minutes

Adaptive Biotechnologies Corporation (ADPT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.1250+0.1150 (+3.82%)
As of 12:14PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-225,250
-225,250
-200,191
-207,279
-146,227
Depreciation & amortisation
22,231
22,231
20,920
13,953
8,472
Stock-based compensation
62,908
62,908
55,477
43,251
24,761
Change in working capital
-46,183
-46,183
-71,546
-56,816
-40,799
Accounts receivable
2,032
2,032
-22,648
-7,362
2,613
Inventory
-2,838
-2,838
817
-5,200
-4,994
Other working capital
-167,021
-167,021
-200,294
-254,473
-168,486
Other non-cash items
12,392
12,392
8,193
6,950
3,337
Net cash provided by operating activities
-156,324
-156,324
-183,945
-192,727
-149,683
Cash flows from investing activities
Investments in property, plant and equipment
-10,697
-10,697
-16,349
-61,746
-18,803
Purchases of investments
-429,558
-429,558
-278,778
-316,544
-694,965
Sales/maturities of investments
569,902
569,902
298,032
559,500
596,724
Net cash used for investing activities
129,647
129,647
2,905
181,210
-117,044
Cash flows from financing activities
Common stock issued
-
-
0
0
272,160
Other financing activities
-
-
124,375
429
-321
Net cash used provided by (used for) financing activities
2,245
2,245
132,265
27,146
293,587
Net change in cash
-24,432
-24,432
-48,775
15,629
26,860
Cash at beginning of period
92,428
92,428
141,203
125,574
98,714
Cash at end of period
67,996
67,996
92,428
141,203
125,574
Free cash flow
Operating cash flow
-156,324
-156,324
-183,945
-192,727
-149,683
Capital expenditure
-10,697
-10,697
-16,349
-61,746
-18,803
Free cash flow
-167,021
-167,021
-200,294
-254,473
-168,486